Recently, exome sequencing identified G→T transversion mutation in several genes including ARID1A, KRAS and TP53 in liver fluke-related bile duct cancers, and functional analysis of ARID1A demonstrated a tumor suppressive function, suggesting the role of chromatin modulators in cholangiocarcinoma pathogenesis [60]. This evidence concerns the gene TP53 and bile duct cancer.